Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.
- NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.
- NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion evidence source_evidence_literature NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.
- NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion SIO_000772 12738753 NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.
- NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion wasDerivedFrom befree-2016 NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.
- NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion wasGeneratedBy ECO_0000203 NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.
- befree-2016 importedOn "2016-02-19" NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.